Abstract
Membrane-bound matrix metalloproteinase 16 (MMP16/MT3-MMP) is considered a drug target due to its role(s) in disease processes such as cancer and inflammation. Biochemical characterization of MMP16 is critical for developing new generation MMP inhibitors (MMPi), which exhibit high efficacies and selectivities. Herein, a modified over-expression and purification protocol was used to prepare the catalytic domain of MMP16 (cdMMP16). The resulting recombinant enzyme exhibited steady-state kinetic constants of K m = 10.6 ± 0.7 μM and k cat = 1.14 ± 0.02 s−1, when using FS-6 as substrate, and the enzyme bound 1.8 ± 0.1 eq of Zn(II). The enzymatic activity of cdMMP16 is salt concentration-dependent, and cdMMP16 exhibits autoproteolytic activity under certain conditions, which may be related to an in vivo regulatory mechanism of MMP16 and of other membrane-type MMPs (MT-MMPs). Co(II)-substituted analogs (Co2- and ZnCo) of cdMMP16 were prepared and characterized using several spectroscopic techniques, such as UV–Vis, 1H NMR, and EXAFS spectroscopies. A well-characterized cdMMP16 is now available for future inhibitor screening efforts.
Similar content being viewed by others
Abbreviations
- DNP:
-
2,4-Dinitrophenyl
- EDTA:
-
Ethylenediaminetetraacetic acid
- EPR:
-
Electron paramagnetic resonance
- EXAFS:
-
Extended X-ray absorption fine structure
- Hepes:
-
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid
- IPTG:
-
Isopropyl-β-d-thiogalactoside
- MALDI-TOF:
-
Matrix-assisted laser desorption/ionization-time of flight
- MCA:
-
(7-Methoxycoumarin-4-yl) acetic acid
- MMP:
-
Matrix metalloproteinases
- MT-MMP:
-
Membrane-type matrix metalloproteiniases
- NMR:
-
Nuclear magnetic resonance
- OP:
-
Phenanthroline
- SDS:
-
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
- Tris:
-
Tris(hydroxymethyl)aminomethane
References
Nagase H, Visse R, Murphy G (2006) Cardiovasc Res 69:562–573
Itoh Y (2015) Matrix Biol 44–46:207–223
Rodriguez D, Morrison CJ, Overall CM (2010) Biochim Biophys Acta 1803:39–54
Gialeli C, Theocharis AD, Karamanos NK (2011) FEBS J 278:16–27
Kessenbrock K, Plaks V, Werb Z (2010) Cell 141:52–67
Fingleton B (2008) Semin Cell Dev Biol 19:61–68
Elisa N, Tiziano T, Armando R (2007) Curr Pharm Des 13:2087–2100
Jacobsen JA, Major Jourden JL, Miller MT, Cohen SM (2010) Biochim Biophys Acta 1803:72–94
Van Lint P, Libert C (2007) J Leukoc Biol 82:1375–1381
Dufour A, Overall CM (2013) Trends Pharmacol Sci 34:233–242
Butler GS, Overall CM (2013) Periodontol 2000(63):123–148
Gutierrez-Fernandez A, Fueyo A, Folgueras AR, Garabaya C, Pennington CJ, Pilgrim S, Edwards DR, Holliday DL, Jones JL, Span PN, Sweep FC, Puente XS, Lopez-Otin C (2008) Cancer Res 68:2755–2763
Visse R, Nagase H (2003) Circ Res 92:827–839
Bode W, Fernandez-Catalan C, Tschesche H, Grams F, Nagase H, Maskos K (1999) Cell Mol Life Sci CMLS 55:639–652
Tallant C, Marrero A, Gomis-Rüth FX (2010) Biochim Biophys Acta 1803:20–28
Van Wart HE, Birkedal-Hansen H (1990) Proc Natl Acad Sci 87:5578–5582
Massova I, Kotra LP, Mobashery S (1998) Bioorg Med Chem Lett 8:853–858
Rao BG (2005) Curr Pharm Des 11:295–322
Loretta A, Magda G, Ilaria C, Susanna M, Giovanni Francesco F, Stefano M, Paolo A, Alessandra T, Massimo C (2008) Curr Med Chem 15:2192–2222
Tochowicz A, Goettig P, Evans R, Visse R, Shitomi Y, Palmisano R, Ito N, Richter K, Maskos K, Franke D (2011) J Biol Chem 286:7587–7600
Verma RP, Hansch C (2007) Bioorg Med Chem 15:2223–2268
Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y (1997) Cancer Res 57:2055–2060
Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y (1999) Am J Pathol 154:417–428
Plaisier M, Kapiteijn K, Koolwijk P, Fijten C, Hanemaaijer R, Grimbergen JM, Mulder-Stapel A, Quax PH, Helmerhorst FM, van Hinsbergh VW (2004) J Clin Endocrinol Metab 89:5828–5836
Yoshiyama Y, Sato H, Seiki M, Shinagawa A, Takahashi M, Yamada T (1998) Acta Neuropathol 96:347–350
Tatti O, Gucciardo E, Pekkonen P, Holopainen T, Louhimo R, Repo P, Maliniemi P, Lohi J, Rantanen V, Hautaniemi S, Alitalo K, Ranki A, Ojala PM, Keski-Oja J, Lehti K (2015) Cancer Res 75:2083–2094
Cho NH, Shim HS, Rha SY, Kang SH, Hong SH, Choi YD, Hong SJ, Cho SH (2003) Eur Urol 44:560–566
Li Y, Wang Y, Yu L, Sun C, Cheng D, Yu S, Wang Q, Yan Y, Kang C, Jin S, An T, Shi C, Xu J, Wei C, Liu J, Sun J, Wen Y, Zhao S, Kong Y (2013) Cancer Lett 339:260–269
Liu J, van Mil A, Aguor EN, Siddiqi S, Vrijsen K, Jaksani S, Metz C, Zhao J, Strijkers GJ, Doevendans PA, Sluijter JP (2012) J Cell Mol Med 16:2379–2386
Takino T, Koshikawa N, Miyamori H, Tanaka M, Sasaki T, Okada Y, Seiki M, Sato H (2003) Oncogene 22:4617–4626
Lee J-H, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR (1996) J Natl Cancer Inst 88:1731–1737
Skorupskaite K, George JT, Anderson RA (2014) Hum Reprod Update 20:485–500
Ahmad M, Takino T, Miyamori H, Yoshizaki T, Furukawa M, Sato H (2006) J Biochem 139:517–526
Lang R, Braun M, Sounni NE, Noel A, Frankenne F, Foidart JM, Bode W, Maskos K (2004) J Mol Biol 336:213–225
Greenfield NJ (2006) Nat Protoc 1:2876–2890
Whitmore L, Wallace BA (2004) Nucleic Acids Res 32:W668–W673
Yang H, Makaroff K, Paz N, Aitha M, Crowder MW, Tierney DL (2015) Biochemistry 54:3631–3639
Wetmore DR, Hardman KD (1996) Biochemistry 35:6549–6558
Cha J, Pedersen MV, Auld DS (1996) Biochemistry 35:15831–15838
Tierney DL, Schenk G (2014) Biophys J 107:1263–1272
George G, Pickering I (1995) EXAFSPAK: A suite of computer programs for analysis of X-ray absorption spectra. Stanford Synchroton Radiation Laboratory, Stanford, CA
Webb S (2005) Phys Scr 2005:1011
Neumann U, Kubota H, Frei K, Ganu V, Leppert D (2004) Anal Biochem 328:166–173
de Mol NJ, Fischer MJ (2008) In: Schasfoort RBM, Tudos AJ (eds) Handbook of surface plasmon resonance. RSC Publishing, London, pp 123–172
Kuzmic P (2009) Methods Enzymol 467:247–280
Cha J, Sørensen VM, Ye Q-Z, Auld SD (1998) J Biol Inorg Chem 3:353–359
Bertini I, Fragai M, Lee YM, Luchinat C, Terni B (2004) Angew Chem (International ed. in English) 43:2254–2256
Garmer DR, Krauss M (1993) J Am Chem Soc 115:10247–10257
Breece RM, Costello A, Bennett B, Sigdel TK, Matthews ML, Tierney DL, Crowder MW (2005) J Biol Chem 280:11074–11081
Sabel CE, Carbone R, Dabous JR, Lo SY, Siemann S (2011) Biochem Biophys Res Commun 416:106–110
Lichty J, Allen SM, Grillo AI, Archibald SJ, Hubin TJ (2004) Inorg Chim Acta 357:615–618
Bertini I, Luchinat C (1983) Acc Chem Res 16:272–279
Banci L, Bencini A, Benelli C, Gatteschi D, Zanchini C (1982) Struct Bonding 52:37–86
Vallejo LF, Rinas U (2004) Microb Cell Fact 3:11
Inouye K, Tanaka H, Oneda H (2000) J Biochem 128:363–369
Royer CA (2006) Chem Rev 106:1769–1784
Lehti K, Lohi J, Valtanen H, Keski-Oja J (1998) Biochem J 334(Pt 2):345–353
Tatti O, Arjama M, Ranki A, Weiss SJ, Keski-Oja J, Lehti K (2011) PLoS ONE 6:e28325
DeLano WL (2002) CCP4 Newsletter on protein crystallography 40:82–92
Acknowledgments
This work was supported by the National Institutes of Health (P30-EB-009998 to the Center for Synchrotron Biosciences from the NIBIB, which supports beamline X3B at the NSLS) and the National Science Foundation (CHE-1151658 to MWC and DLT). The authors thank Theresa Ramelot for assistance in obtaining 1H NMR spectra on the enzymes.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Meng, F., Yang, H., Aitha, M. et al. Biochemical and spectroscopic characterization of the catalytic domain of MMP16 (cdMMP16). J Biol Inorg Chem 21, 523–535 (2016). https://doi.org/10.1007/s00775-016-1362-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-016-1362-y